Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Mi Jeong | - |
dc.contributor.author | Park, Ji Eun | - |
dc.contributor.author | Lee, Shin Yup | - |
dc.contributor.author | Lee, Jang Hyuck | - |
dc.contributor.author | Choi, Jin Eun | - |
dc.contributor.author | Kang, Hyo-Gyoung | - |
dc.contributor.author | Do, Sook Kyung | - |
dc.contributor.author | Jeong, Ji Yun | - |
dc.contributor.author | Shin, Kyung Min | - |
dc.contributor.author | Lee, Won Ki | - |
dc.contributor.author | Seok, Yangki | - |
dc.contributor.author | Choi, Sun Ha | - |
dc.contributor.author | Lee, Yong Hoon | - |
dc.contributor.author | Seo, Hyewon | - |
dc.contributor.author | Yoo, Seung Soo | - |
dc.contributor.author | Lee, Jaehee | - |
dc.contributor.author | Cha, Seung Ick | - |
dc.contributor.author | Kim, Chang Ho | - |
dc.contributor.author | Park, Jae Yong | - |
dc.date.accessioned | 2023-05-25T01:41:47Z | - |
dc.date.available | 2023-05-25T01:41:47Z | - |
dc.date.issued | 2022-12 | - |
dc.identifier.issn | 1837-9664 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/22457 | - |
dc.description.abstract | Pemetrexed is an anti-folate agent which is one of the most frequently used chemotherapy agents for non-squamous non-small cell lung cancer (NSCLC) patients. However, clinical response to pemetrexed chemotherapy and survival outcome of patients varies significantly. We evaluated whether the genetic variants in miRNA target sites may affect the treatment outcome of pemetrexed chemotherapy in lung adenocarcinoma patients. One hundred SNPs in miRNA binding regions in cancer-related genes were obtained from the crosslinking, ligation, and sequencing of hybrids (CLASH) and CancerGenes database, and the associations with the response to pemetrexed chemotherapy and survival outcomes were investigated in 314 lung adenocarcinoma patients. Two polymorphisms, EXO1 rs1047840G>A and CAMKK2 rs1653586G>T, were significantly associated with worse chemotherapy response (adjusted odds ratio [aOR] = 0.41, 95% CI = 0.24-0.68, P = 0.001, under dominant model; and aOR = 0.33, 95% CI = 0.16-0.67, P = 0.002, under dominant model, respectively) and worse OS (adjusted hazard ratio [aHR] = 1.34, 95% CI = 1.01-1.77, P = 0.04, under dominant model; and aHR = 1.50, 95% CI = 1.06-2.13, P = 0.02, under dominant model, respectively) in multivariate analyses. Significantly increased luciferase activity was noted in EXO1 rs1047840 A allele compared to G allele. In conclusion, two SNPs in miRNA binding sites, especially EXO1 rs1047840G>A, were associated with the chemotherapy response and survival outcome in lung adenocarcinoma patients treated with pemetrexed. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Ivyspring International Publisher | - |
dc.title | Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma | - |
dc.type | Article | - |
dc.publisher.location | 호주 | - |
dc.identifier.doi | 10.7150/jca.78498 | - |
dc.identifier.scopusid | 2-s2.0-85143512558 | - |
dc.identifier.wosid | 000894007900003 | - |
dc.identifier.bibliographicCitation | Journal of Cancer, v.13, no.15, pp 3701 - 3709 | - |
dc.citation.title | Journal of Cancer | - |
dc.citation.volume | 13 | - |
dc.citation.number | 15 | - |
dc.citation.startPage | 3701 | - |
dc.citation.endPage | 3709 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | EXO1 GENE | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | POLYMORPHISMS | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | SUSCEPTIBILITY | - |
dc.subject.keywordPlus | RECOMBINATION | - |
dc.subject.keywordPlus | SENSITIVITY | - |
dc.subject.keywordPlus | POPULATION | - |
dc.subject.keywordPlus | MICRORNAS | - |
dc.subject.keywordPlus | PLATINUM | - |
dc.subject.keywordAuthor | lung adenocarcinoma | - |
dc.subject.keywordAuthor | miRNA target sites | - |
dc.subject.keywordAuthor | genetic variants | - |
dc.subject.keywordAuthor | chemotherapy | - |
dc.subject.keywordAuthor | response | - |
dc.subject.keywordAuthor | survival | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.